Asacol HD

Asacol HD is a prescription delayed-release formulation of mesalamine, an anti-inflammatory drug. It is specifically designed to release the active medicine in the terminal ileum and colon to treat inflammation caused by ulcerative colitis.

Dosage by Body Weight

The recommended adult dosage is 1.6 g (two 800 mg tablets) taken three times daily, for a total daily dose of 4.8 g, for a duration of 6 weeks. Do not cut, crush, or chew the tablets; they must be swallowed whole.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness of Asacol HD in pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness of Asacol HD in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness of Asacol HD in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness of Asacol HD in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness of Asacol HD in pediatric patients have not been established.

Formulation

Delayed-Release Tablet

Purpose

Treatment of moderately active ulcerative colitis in adults.

Generic Name

Mesalamine

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

LialdaDelzicolAprisoPentasa

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.